Drug Profile
Nimesulide/pantoprazole - EMS
Alternative Names: Pantoprazole/nimesulide - EMSLatest Information Update: 24 Mar 2021
Price :
$50
*
At a glance
- Originator EMS
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Antipyretics; Antirheumatics; Antiulcers; Benzimidazoles; Gastric antisecretories; Nitrobenzenes; Nonsteroidal anti-inflammatories; Pyridines; Small molecules; Sulfonamides; Sulfoxides
- Mechanism of Action Calcium channel antagonists; Cyclo-oxygenase 2 inhibitors; Platelet aggregation inhibitors; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dyspepsia; Inflammation
Most Recent Events
- 24 Mar 2021 No development reported - Phase-III for Dyspepsia in Brazil (PO)
- 24 Mar 2021 No development reported - Phase-III for Inflammation in Brazil (PO)
- 28 Nov 2018 Chemical structure info added